The Significance of Recognition of Human Epidermal Growth Factor 2 Low in Breast Cancer Therapy
The Ohio State University Wexner Medical Center, Columbus, OH
G.T.: AstraZeneca, Faculty Advisory Board, Precision Medicine Steering Committee, Speaker Bureau. Roche, Speaker Bureau.
Reprints: Gary Tozbikian, MD, Department of Pathology, Wexner Medical Center at The Ohio State University, 410 W. 10th Ave, E414 Doan Hall, Columbus, OH 43210 (e-mail: [email protected]).
留言 (0)